{"mainPropery":{"diseaseId":9775,"diseaseName":"Dowling-Degos disease","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9775/dowling-degos-disease","synonyms":["Reticulate acropigmentation of Kitamura","Reticular pigment anomaly of flexures","Dowling-Degos Kitamura disease","Kitamura reticulate acropigmentation"],"synonyms-with-source":[{"name":"Reticulate acropigmentation of Kitamura"},{"name":"Reticular pigment anomaly of flexures"},{"name":"Dowling-Degos Kitamura disease"},{"name":"Kitamura reticulate acropigmentation"}],"identifiers":[{"identifierType":"OMIM","identifierId":"179850"},{"identifierType":"OMIM","identifierId":"615327"},{"identifierType":"OMIM","identifierId":"615674"},{"identifierType":"OMIM","identifierId":"615696"},{"identifierType":"ORPHANET","identifierId":"79145"},{"identifierType":"UMLS","identifierId":"C0406811"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n<a href='http://www.omim.org/179850' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a><br /><a href='http://www.omim.org/615327' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a><br /><a href='http://www.omim.org/615674' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a><br /><a href='http://www.omim.org/615696' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://pubmed.ncbi.nlm.nih.gov/?term=Dowling-degos' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Dowling-Degos disease. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/dowling-degos-disease' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Dowling-Degos disease. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0406811' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1118586-overview#showall' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79145' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/MONDO:0008371' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6735,"questionText":"What is Dowling-Degos disease?","answerText":"<strong>Dowling-Degos disease</strong> is characterized by a lacy or net-like (reticulate) pattern of abnormally dark skin coloring (hyperpigmentation) in the body's folds and creases. Other&nbsp;features may include abnormal growths and pus-filled swellings in the armpits, back, and neck. Symptoms typically develop in late childhood or in adolescence and progress over time. The classic form of Dowling-Degos disease occurs when the <em><a href=\"https://ghr.nlm.nih.gov/gene/KRT5\" target=\"_blank\">KRT5</a></em>&nbsp;gene is not working correctly. This condition is inherited in an autosomal dominant pattern. The skin changes caused by Dowling-Degos disease can be distressing, but they typically&nbsp;don't cause&nbsp;health problems.[15695][15696][15697]","dateModified":"2020-07-02T00:00:00"},"basicQuestions":[{"questionId":6737,"questionText":"What are the symptoms of Dowling-Degos disease?&nbsp;","answerText":"The following list includes the most common signs and symptoms in people with Dowling-Degos disease. These features may be different from person to person. Some people may have more symptoms than others and symptoms can range from mild to severe. This list does not include every symptom or feature that has been described in this condition.&nbsp;<br />\r\n<br />\r\nSigns and symptoms may include:[15695][15696]\r\n<ul>\r\n    <li>Dark skin coloring (hyperpigmentation) in body folds and creases</li>\r\n    <li>Skin nodules (abnormal growths)</li>\r\n    <li>Skin abscesses (pus-filled bumps)</li>\r\n    <li>Pitted scars</li>\r\n</ul>\r\nThe skin changes usually begin in late childhood or in adolescence. Areas of hyperpigmentation and other skin changes tend to increase over time. The skin changes caused by Dowling-Degos disease can cause distress and anxiety, but typically cause no long term medical problems.[15695]<br />","dateModified":"2020-07-02T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":15695,"authors":"Rice AS, Cook C","articleTitle":"Dowling Degos Disease","bookWebsiteJournalTitle":"StatPearls","date":"Apr 2020","volume":"","pages":"","url":"https://pubmed.ncbi.nlm.nih.gov/30285365","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15696,"authors":"Agut-Busquet E, Gonz√°lez-Villanueva I, Romani de Gabriel J, Pascual JC, Ribera Pibernat M, Luelmo J","articleTitle":"Dowling-Degos Disease and Hidradenitis Suppurativa. Epidemiological and Clinical Study of 15 Patients and Review of the Literature","bookWebsiteJournalTitle":"Acta Derm Venereol","date":"2019","volume":"99(10)","pages":"917-918","url":"https://pubmed.ncbi.nlm.nih.gov/31120546","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13555,"questionText":"How is Dowling-Degos disease inherited?","answerText":"Dowling-Degos disease is inherited in an autosomal dominant pattern.[15695][15697] All individuals inherit two copies of each gene. Autosomal means the gene is found on one of the numbered chromosomes found in both sexes. Dominant means that only one altered copy of a gene is necessary to have the condition. The alteration can be inherited from either parent. Sometimes an autosomal dominant condition occurs because of a new genetic alteration (de novo), and there is no history of this condition in the family.&nbsp;&nbsp;<br />\r\n<br />\r\nEach child of an individual with an autosomal dominant condition has a 50% or 1 in 2 chance of inheriting the alteration and the condition. Typically, children who inherit a dominant alteration will have the condition, but they may be more or less severely affected than their parent. Sometimes a person may have a gene alteration for an autosomal dominant condition and show no signs or symptoms of the condition.<br />","dateModified":"2020-07-02T16:12:00","resourceClassificationName":"Inheritance","references":[{"referenceId":15695,"authors":"Rice AS, Cook C","articleTitle":"Dowling Degos Disease","bookWebsiteJournalTitle":"StatPearls","date":"Apr 2020","volume":"","pages":"","url":"https://pubmed.ncbi.nlm.nih.gov/30285365","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15697,"authors":"Mohanty P, Jai S, Mohapatra L, Acharya S","articleTitle":"Dowling-Degos Disease - A Novel Presentation of An Uncommon Disease","bookWebsiteJournalTitle":"Indian Dermatol Online J","date":"2019","volume":"10(5)","pages":"587-590","url":"https://pubmed.ncbi.nlm.nih.gov/31544084","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13553,"questionText":"How is Dowling-Degos disease diagnosed?","answerText":"Dowling-Degos disease is diagnosed based on the result of a clinical exam and a microscopic examination of a small piece of skin (<a href=\"https://medlineplus.gov/ency/article/003840.htm\" target=\"_blank\">skin biopsy</a>).[15695][15696]","dateModified":"2020-07-02T15:34:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":15695,"authors":"Rice AS, Cook C","articleTitle":"Dowling Degos Disease","bookWebsiteJournalTitle":"StatPearls","date":"Apr 2020","volume":"","pages":"","url":"https://pubmed.ncbi.nlm.nih.gov/30285365","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15696,"authors":"Agut-Busquet E, Gonz√°lez-Villanueva I, Romani de Gabriel J, Pascual JC, Ribera Pibernat M, Luelmo J","articleTitle":"Dowling-Degos Disease and Hidradenitis Suppurativa. Epidemiological and Clinical Study of 15 Patients and Review of the Literature","bookWebsiteJournalTitle":"Acta Derm Venereol","date":"2019","volume":"99(10)","pages":"917-918","url":"https://pubmed.ncbi.nlm.nih.gov/31120546","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6736,"questionText":"How might Dowling-Degos disease be treated?","answerText":"Treatment for Dowling-Degos disease (DDD) is focused on managing the symptoms. Because most treatments have limited success, it is often necessary for people with DDD to try different treatment methods.[15695][15696][15697]<br />\r\n<br />\r\nOne specialist who may be involved in the care of someone with Dowling-Degos disease is a dermatologist.&nbsp;<br />","dateModified":"2020-07-02T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":15695,"authors":"Rice AS, Cook C","articleTitle":"Dowling Degos Disease","bookWebsiteJournalTitle":"StatPearls","date":"Apr 2020","volume":"","pages":"","url":"https://pubmed.ncbi.nlm.nih.gov/30285365","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15696,"authors":"Agut-Busquet E, Gonz√°lez-Villanueva I, Romani de Gabriel J, Pascual JC, Ribera Pibernat M, Luelmo J","articleTitle":"Dowling-Degos Disease and Hidradenitis Suppurativa. Epidemiological and Clinical Study of 15 Patients and Review of the Literature","bookWebsiteJournalTitle":"Acta Derm Venereol","date":"2019","volume":"99(10)","pages":"917-918","url":"https://pubmed.ncbi.nlm.nih.gov/31120546","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15697,"authors":"Mohanty P, Jai S, Mohapatra L, Acharya S","articleTitle":"Dowling-Degos Disease - A Novel Presentation of An Uncommon Disease","bookWebsiteJournalTitle":"Indian Dermatol Online J","date":"2019","volume":"10(5)","pages":"587-590","url":"https://pubmed.ncbi.nlm.nih.gov/31544084","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13552,"questionText":"What is the cause of Dowling-Degos disease?","answerText":"The classic form of Dowling-Degos disease occurs when the <em><a href=\"https://ghr.nlm.nih.gov/gene/KRT5\" target=\"_blank\">KRT5</a></em> gene is not working correctly. Other, less common forms, are associated with the <em><a href=\"https://ghr.nlm.nih.gov/gene/POFUT1://\" target=\"_blank\">POFUT1</a></em> and the <em><a href=\"https://ghr.nlm.nih.gov/gene/POGLUT1\" target=\"_blank\">POGLUT1</a></em> genes<em>. </em>DNA changes known as pathogenic variants are responsible for making genes work incorrectly, or sometimes, not at all.[15696][15698]","dateModified":"2020-07-02T15:19:00","resourceClassificationName":"Cause","references":[{"referenceId":15696,"authors":"Agut-Busquet E, Gonz√°lez-Villanueva I, Romani de Gabriel J, Pascual JC, Ribera Pibernat M, Luelmo J","articleTitle":"Dowling-Degos Disease and Hidradenitis Suppurativa. Epidemiological and Clinical Study of 15 Patients and Review of the Literature","bookWebsiteJournalTitle":"Acta Derm Venereol","date":"2019","volume":"99(10)","pages":"917-918","url":"https://pubmed.ncbi.nlm.nih.gov/31120546","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15698,"authors":"Wilson NJ, Cole C, Kroboth K, et al","articleTitle":"Mutations in POGLUT1 in Galli-Galli/Dowling-Degos disease","bookWebsiteJournalTitle":"Br J Dermatol. 2017;176(1):270-274","date":"2017","volume":"176(1)","pages":"270-274","url":"https://pubmed.ncbi.nlm.nih.gov/27479915","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13554,"questionText":"How many people have Dowling-Degos disease?","answerText":"Less than 50 cases of Dowling-Degos disease (DDD) have been reported in the medical literature. It is unknown exactly how many people have DDD.[15695]","dateModified":"2020-07-02T16:01:00","resourceClassificationName":"Statistics","references":[{"referenceId":15695,"authors":"Rice AS, Cook C","articleTitle":"Dowling Degos Disease","bookWebsiteJournalTitle":"StatPearls","date":"Apr 2020","volume":"","pages":"","url":"https://pubmed.ncbi.nlm.nih.gov/30285365","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":15695,"authors":"Rice AS, Cook C","articleTitle":"Dowling Degos Disease","bookWebsiteJournalTitle":"StatPearls","date":"Apr 2020","volume":"","pages":"","url":"https://pubmed.ncbi.nlm.nih.gov/30285365","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15696,"authors":"Agut-Busquet E, Gonz√°lez-Villanueva I, Romani de Gabriel J, Pascual JC, Ribera Pibernat M, Luelmo J","articleTitle":"Dowling-Degos Disease and Hidradenitis Suppurativa. Epidemiological and Clinical Study of 15 Patients and Review of the Literature","bookWebsiteJournalTitle":"Acta Derm Venereol","date":"2019","volume":"99(10)","pages":"917-918","url":"https://pubmed.ncbi.nlm.nih.gov/31120546","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15697,"authors":"Mohanty P, Jai S, Mohapatra L, Acharya S","articleTitle":"Dowling-Degos Disease - A Novel Presentation of An Uncommon Disease","bookWebsiteJournalTitle":"Indian Dermatol Online J","date":"2019","volume":"10(5)","pages":"587-590","url":"https://pubmed.ncbi.nlm.nih.gov/31544084","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15698,"authors":"Wilson NJ, Cole C, Kroboth K, et al","articleTitle":"Mutations in POGLUT1 in Galli-Galli/Dowling-Degos disease","bookWebsiteJournalTitle":"Br J Dermatol. 2017;176(1):270-274","date":"2017","volume":"176(1)","pages":"270-274","url":"https://pubmed.ncbi.nlm.nih.gov/27479915","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":6780,"phenoTypeName":"Hyperkeratotic papule","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":5326,"phenoTypeName":"Epidermal acanthosis","percentRanges":"-"},{"phenoTypeId":892,"phenoTypeName":"Follicular hyperkeratosis","percentRanges":"-"},{"phenoTypeId":5347,"phenoTypeName":"Hypergranulosis","percentRanges":"-"},{"phenoTypeId":12131,"phenoTypeName":"Hyperpigmented/hypopigmented macules","percentRanges":"-"},{"phenoTypeId":15146,"phenoTypeName":"Hypomelanotic macule","percentRanges":"-"},{"phenoTypeId":3136,"phenoTypeName":"Progressive reticulate hyperpigmentation","percentRanges":"-"},{"phenoTypeId":10506,"phenoTypeName":"Reticular hyperpigmentation","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Dowling-Degos_disease"}